HB 570-FN - AS AMENDED BY THE HOUSE
13Mar2025... 0190h
2025 SESSION
25-0079
05/02
HOUSE BILL 570-FN
AN ACT repealing the prescription drug affordability board.
SPONSORS: Rep. Edwards, Rock. 31; Sen. Rosenwald, Dist 13
COMMITTEE: Executive Departments and Administration
-----------------------------------------------------------------
AMENDED ANALYSIS
This bill repeals the prescription drug affordability board.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
13Mar2025... 0190h 25-0079
05/02
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty Five
AN ACT repealing the prescription drug affordability board.
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 Salaries Established. Amend RSA 94:1-a, I(b) by deleting in GG:
GG Department of heath and human services executive director, prescription
drug affordability board
2 Repeal. The following are repealed:
I. RSA 6:12, I(b)(384), relative to the New Hampshire prescription drug affordability board administration fund.
II. RSA 126-BB, relative to the prescription drug affordability board.
3 Effective Date. This act shall take effect July 1, 2025.
25-0079
1/3/25
HB 570-FN- FISCAL NOTE
AS INTRODUCED
FISCAL IMPACT: This bill does not provide funding.
|
| |||||
Estimated State Impact | ||||||
| FY 2025 | FY 2026 | FY 2027 | FY 2028 | ||
Revenue | $0 | $0 | $0 | $0 | ||
Revenue Fund(s) | None | |||||
Expenditures* | $0 | $140,000 | $148,000 | $153,000 | ||
Funding Source(s) | General Fund | |||||
Appropriations* | $0 | $0 | $0 | $0 | ||
Funding Source(s) | None | |||||
*Expenditure = Cost of bill *Appropriation = Authorized funding to cover cost of bill | ||||||
METHODOLOGY:
This bill extends until 2030 the position of executive director for the Prescription Drug Affordability Board (PDAB). Currently, state statue establishes the position for only two years following the date of hire of the individual first selected to fill the position. The PDAB states that salary and benefits for the position will be approximately $140,000 in FY26, $148,000 in FY27, and $153,000 in FY28. These will be paid for with state general funds.
AGENCIES CONTACTED:
Prescription Drug Affordability Board
| Date | Amendment |
|---|---|
| March 5, 2025 | 2025-0190h |
| Date | Body | Type |
|---|---|---|
| Jan. 29, 2025 | House | Hearing |
| Feb. 19, 2025 | House | Exec Session |
| Feb. 19, 2025 | House | Floor Vote |
| April 1, 2025 | House | Exec Session |
April 2, 2025: Retained in Committee
March 26, 2025: Executive Session: 04/01/2025 10:00 am LOB 210-211
March 19, 2025: Division III Work Session: 03/21/2025 01:00 pm LOB 210-211
March 13, 2025: Referred to Finance 03/13/2025 HJ 8 P. 76
March 13, 2025: Ought to Pass with Amendment 2025-0190h: MA DV 205-168 03/13/2025 HJ 8 P. 76
March 13, 2025: Amendment # 2025-0190h (NT): AA VV 03/13/2025 HJ 8 P. 74
March 13, 2025: Lay HB 570 on Table (Rep. Grote): MF RC 167-207 03/13/2025 HJ 8 P. 74
March 5, 2025: Minority Committee Report: Inexpedient to Legislate
March 5, 2025: Majority Committee Report: Ought to Pass with Amendment # 2025-0190h (NT) 02/19/2025 (Vote 9-7; RC)
Feb. 12, 2025: Executive Session: 02/19/2025 02:00 pm LOB 306-308
Jan. 22, 2025: Public Hearing: 01/29/2025 02:00 pm LOB 306-308
Jan. 16, 2025: Introduced (in recess of) 01/09/2025 and referred to Executive Departments and Administration HJ 3 P. 17